EnLyte Recently Approved for Use in Women of Childbearing Age Who May Become Pregnant

EnLyte, advanced generation prescription folate therapy, has received approval to be used in women of childbearing age who may become pregnant, and is pregnancy category A treatment for depression, according to JayMac Pharmaceuticals, LLC.

Sunset, LA (PRWEB) March 26, 2014

EnLyte, advanced generation prescription folate therapy, has received approval to be used in women of childbearing age who may become pregnant, and is pregnancy category A treatment for depression, according to JayMac Pharmaceuticals, LLC.

Although planning and becoming pregnant can be the happiest time in a woman's life, mood changes are common during this time. In fact, depression is the most common psychiatric disorder associated with pregnancy, and it is imperative that it be treated with therapies that fully address the depression, while posing the least threat to the developing fetus.

Many women may have concerns with taking a prescribed antidepressant, but when left untreated, depression can lead to many negative outcomes, including poor prenatal care, alcohol and drug use, self-medicating., and even exacerbated post partum depression.

EnLyte is an advanced generation folate therapy available by prescription. It provides complete care for treating depression before, during, and after pregnancy, and has a Pregnancy category A rating. EnLyte contains the following optimal ingredients, and is the first prescription folate to combine the power of this combination: L-Methylfolate Magnesium, Folinic Acid, Folic Acid, plus all of the metabolized, brain-ready cofactors and minerals needed to get to the root cause of depression in a safe, natural way. It also contains a trace amount of iron chelate, to serve as a gut carrier in folate absorption. According to Dr. Andrew Farah, Chief of Psychiatry, UNC/High Point Regional Health Systems, "Enlyte is the ideal prenatal vitamin because it contains the form of folate that is most effective at preventing neurological birth defects. It also contains iron, which is not only an important component of any prenatal, but is necessary for optimal folate absorption. It was developed as an antidepressant agent, so of course it is perfect for the patient needing treatment for depression who may be pregnant, or trying to get pregnant. We have also used in it postpartum depression and in those who are breast feeding." View Dr. Farah's case study video for more information: http://youtu.be/VwljkJ1-1C8

Choosing a depressant therapy during conception and pregnancy can be tricky because the scientific data on prescription antidepressant options is evolving. Coupled with the fact that about 50% of pregnancies are unplanned, an effective yet safe choice for both patient and baby can prove challenging for the provider. According to Marlene P. Freeman, MD as published this month in Psychiatric Times, "It is a major treatment dilemma when a woman decides to try to conceive or becomes pregnant while being treated with a particularly risky medication. A switch during pregnancy means that a woman will have more than one medication exposure during her pregnancy, and a trial of a medication that is new to her is complicated by the fact that the risk to benefit ratio for her is unknown. Therefore, the initial selection of psychotropics for women with psychiatric disorders should include consideration of reproductive potential and data regarding use in human pregnancy."

According to the 2010 American Psychiatric Association (APA) Guidelines for Treating Major Depressive Disorder, " Folate is a low-risk intervention with general health benefits. Considering its modest evidence that supports folate as an augmentation strategy and its attractive risk/benefit profile, folate can be recommended as a reasonable adjunctive strategy for major depressive disorder that carries little risk and may decrease birth defects in case of pregnancy."

JayMac Pharmaceuticals is pleased to offer an effective yet safe and natural prescription choice for this important time in a woman's life. EnLyte is a therapy that can be prescribed at any point in the life stage of a woman, and can be used alone or added on to an existing SSRI/SNRI. Dr. Lawrence Ginsberg, M.D., of Red Oak Psychiatry states, " I strongly recommend the use of EnLyte in women who are planning to become pregnant or who are pregnant. EnLyte contains the critical factors such as L-Methylfolate plus the reduced forms of B1, B2, B3, B6, and B12.

For more information on how you may benefit from EnLyte, please visit http://www.EnLyteRx.Com and speak with your medical provider.